Start by mapping every Gemini surface in use, then limit access to covered Google products only. Use Workspace Gemini on a covered SKU with a signed BAA, or Vertex AI under the Google Cloud BAA for applications that call models directly. Block consumer Gemini and AI Studio for PHI. Add data-layer controls so users cannot paste sensitive data into prompts or tool outputs.
Why safe Gemini deployment needs separate trust boundaries
Gemini is not one control plane. Workspace, Vertex AI, and consumer Gemini have different contractual, data-handling, and admin boundaries, so safe rollout starts with an inventory of who can use which surface and for what data. That separation matters most in healthcare, where PHI, auditability, and vendor commitments need to stay aligned with the actual product path.
For managed enterprise use, treat Gemini in Google Workspace as a licensed collaboration capability that should sit inside an approved tenant and covered agreement. For model calls in applications, treat Vertex AI as a cloud service integration that must be governed like any other production AI dependency, including identity, logging, and network controls. Consumer tools do not belong on the same trust boundary as regulated clinical workflows.
How to place PHI, prompts, and connected apps under control
The practical control problem is data movement, not just model access. Healthcare teams need to decide which users may enter PHI, which apps may relay that data to Gemini, and which output paths are allowed to persist or redistribute it. If those decisions are not explicit, prompt text, attachments, and tool outputs become the easiest route for accidental disclosure.
Workspace controls should be paired with DLP, sharing restrictions, and retention rules so that prompt content and generated output are governed as sensitive data. Vertex AI needs equivalent guardrails at the application layer, especially for service-to-service access, logging, and egress. The Google Cloud Vertex AI Security Guide is the most relevant starting point when you are mapping service access, logging, and runtime controls for model-backed applications.
Consumer Gemini and AI Studio should be excluded from any workflow that could contain PHI, because the operational risk is not just accidental entry by one user, but uncontrolled reuse across devices, accounts, and browser sessions. Teams that need a formal policy baseline can adapt NHIMG’s AI Acceptable Use Policy Template to define approved tools, prohibited data classes, and escalation rules.
What healthcare teams should verify before go-live
Before rollout, verify the exact Gemini surface, SKU, and agreement behind each use case. Workspace Gemini should only be enabled where the covered SKU and signed BAA are in place, and Vertex AI should only be used where the Google Cloud BAA and the supporting cloud controls are already approved. This is also the point to confirm who owns the configuration, who reviews logs, and which systems record access and content events.
For user-facing collaboration, one useful control is a published allowlist of approved AI services, paired with onboarding rules that prevent staff from assuming that every Gemini-branded product is equivalent. For engineering teams, an internal register helps track which workflows call models directly, which ones can see PHI, and which ones must be blocked from consumer endpoints. NHIMG’s AI Platforms Guide provides a broader control map for enterprise AI services, including Workspace and cloud model platforms.
Health systems also need a policy for connected apps and data egress. If a browser extension, add-on, or downstream app can move content into or out of Gemini, that path needs the same review as the primary application. For healthcare-specific deployment and clinical data handling, NHIMG’s AI Security in Healthcare Guide is the closest fit for PHI handling, BAAs, and clinical AI governance.
Risk and Threat Considerations
Healthcare use of Gemini creates disclosure risk wherever staff can paste protected data into a prompt, retrieve it through an extension, or send it to a consumer interface outside the approved tenant. The main threat is not model failure alone, but data leaving a governed boundary and becoming difficult to account for, retain, or delete.
Failure mechanism: Users, connected apps, or browser-based workflows move PHI into an unapproved Gemini surface, or they let generated output flow into systems that were never intended to store sensitive clinical data.
Impact: That can create privacy exposure, compliance failures, and incident response complexity, especially when the organisation cannot prove which surface was used, what data was entered, or where the output persisted.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
CSA Cloud Controls Matrix, NIST SP 800-53 Rev 5 and OWASP ASVS set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| CSA Cloud Controls Matrix | IAM — Identity and Access Management | Healthcare Gemini access must be limited by approved tenants and roles. |
| Recommendation — Restrict Gemini access to approved users, apps, and cloud tenants. | ||
| NIST SP 800-53 Rev 5 | IA-2 — Identification and Authentication (Organizational Users) | Workspace and cloud admin access needs strong user authentication and traceability. |
| AU-2 — Event Logging | Gemini use in healthcare needs auditable logs for prompt and access activity. | |
| Recommendation — Enforce strong authentication for admins and privileged AI platform users. Log Gemini access and content events needed for investigation and audit. | ||
| ISO/IEC 27001:2022 | A.5.15 — Access control | Approved Gemini surfaces depend on clear access control rules and enforcement. |
| Recommendation — Define and enforce access rules for approved Gemini services and data. | ||
| OWASP ASVS | V14 Data Protection — Data Protection | Prompt content, outputs, and connected data paths must protect sensitive information. |
| Recommendation — Protect PHI in prompts, outputs, and linked application flows. | ||
Practitioner Guidance
What to prioritise: Start with a surface-by-surface inventory, then classify each use case by data sensitivity and contract coverage. The first decision is not model quality, it is whether the workflow belongs in Workspace, Vertex AI, or nowhere near consumer Gemini.
What to verify: Confirm that the approved route has the right BAA, that consumer access is technically blocked for PHI workflows, and that logging or audit trails can reconstruct who used the tool and through which application path. If you cannot verify those three points, the use case is not ready.
Decision rule: If a workflow can touch PHI, route it only through the covered enterprise path and add prompt, DLP, and output restrictions; if the workflow cannot be constrained that way, keep it out of Gemini entirely.
Practitioner takeaway: Safe Gemini adoption in healthcare is mainly a boundary-setting exercise, so the organisation that wins is the one that can prove where data may flow before it tries to optimise the user experience.
Related resources from NHI Mgmt Group
- How should security teams implement GenAI stress testing across different AI systems and use cases?
- How should organisations implement a data catalog to support both governance and AI use cases across a fragmented data estate?
- How should security teams govern AI use cases across multiple business units?
- How should organisations measure trust across AI use cases, agents, and models?
Deepen Your Knowledge
Free weekly newsletter
Subscribe to the NHI & AI Identity Journal
The latest on NHI and Agentic AI security – articles, research, breaches, news and events every week.
Bonus 33% off our NHI Course when you subscribe.
Reviewed and updated by the NHIMG editorial team on October 31, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org